A new drug has been approved by the European Medicines Agency which could offer better treatment to patients with multiple sclerosis. Alemtuzumab will give people who have the disease the chance to live without the side effects for much longer.
Symptoms of the disease can include loss of physical skills, sensation, vision and bladder control.
Professor Herman Waldmann was involved in the early discovery work of the antibody drug called Campath-1H at Cambridge University. It was originally used to treat leukaemia. He continued to study the drug for two decades while at Oxford University.
More top news
It's one of the biggest music events in the country. Thousands of people have arrived in Berkshire for this year's Reading Festival.
Anyone travelling this weekend is likely to face severe delays. Millions of extra cars are expected on the roads.
The forecast for the Bank Holiday weekend from Helen Plint.